Cytek Biosciences amends severance plan; CEO gets 12-month base, 24-month on change of control

Cytek Biosciences, Inc.

Compensation Committee approved Second Amended and Restated Severance Benefit Plan effective Feb 20, 2024.
Non-CIC termination: CEO receives 12 months base salary + COBRA; other NEOs get 9 months base + COBRA.
CIC termination: CEO receives 24 months base salary + 100% target bonus + 24 months COBRA + full equity vesting.
Other NEOs get 18 months base salary + 100% target bonus + 18 months COBRA + full equity vesting.
Benefits require signed release and compliance with restrictive covenants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.